{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:22:03Z","timestamp":1794345723352,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinre.2026.102928","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:48:11Z","timestamp":1790380091000},"page":"102928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic\u2013therapeutic readiness in Helicobacter pylori management: Aligning diagnostic capability with therapeutic opportunity"],"prefix":"10.1016","volume":"50","author":[{"given":"Toshihiko","family":"Kakiuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clinre.2026.102928_bib0001","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.clinre.2026.102928_bib0002","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG Clinical Guideline: treatment of Helicobacter pylori Infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102928_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinre.2026.102928_bib0004","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","article-title":"Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study","volume":"65","author":"Murakami","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.clinre.2026.102928_bib0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial","volume":"163","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2026.102928_bib0006","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","article-title":"AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review","volume":"167","author":"Patel","year":"2024","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.clinre.2026.102928_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411708","article-title":"Antibiotic resistance, susceptibility testing and stewardship in Helicobacter pylori infection","volume":"24","author":"Ng","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clinre.2026.102928_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00732-23","article-title":"Testing for Helicobacter pylori in an era of antimicrobial resistance","volume":"62","author":"Schuetz","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102928_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12958","article-title":"Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: a systematic review and meta-analysis","volume":"28","author":"Ren","year":"2023","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.clinre.2026.102928_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13133","article-title":"Vonoprazan dual or triple therapy versus bismuth-quadruple therapy as first-line therapy for Helicobacter pylori infection: a three-arm, randomized clinical trial","volume":"29","author":"Cheung","year":"2024","journal-title":"Helicobacter"},{"issue":"2","key":"10.1016\/j.clinre.2026.102928_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"10.1016\/j.clinre.2026.102928_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13012-023-01286-z","article-title":"Ten years of implementation outcomes research: a scoping review","volume":"18","author":"Proctor","year":"2023","journal-title":"Implement Sci"},{"issue":"11","key":"10.1016\/j.clinre.2026.102928_bib0013","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, GenoType HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori","volume":"47","author":"Cambau","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102928_bib0014","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/antibiotics10040437","article-title":"Next Generation Sequencing for the prediction of the antibiotic resistance in Helicobacter pylori: a literature review","volume":"10","author":"Saracino","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.clinre.2026.102928_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5009\/gnl220076","article-title":"Real-time polymerase chain reaction for the detection of Helicobacter pylori and clarithromycin resistance","volume":"17","author":"Noh","year":"2023","journal-title":"Gut Liver"},{"issue":"9","key":"10.1016\/j.clinre.2026.102928_bib0016","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/jgh.15887","article-title":"Smart Gene as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation","volume":"37","author":"Kakiuchi","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102928_bib0017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPG.0000000000003908","article-title":"Helicobacter pylori antimicrobial resistance using next-generation sequencing in stool samples in a pediatric population","volume":"77","author":"Bonilla","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.clinre.2026.102928_bib0018","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S2468-1253(23)00097-3","article-title":"Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials","volume":"8","author":"Chen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2026.102928_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.913436","article-title":"Empirical vs susceptibility-guided treatment of Helicobacter pylori infection: a systematic review and meta-analysis","volume":"13","author":"Nyssen","year":"2022","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102928_bib0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/ueg2.12609","article-title":"Culture-based susceptibility-guided tailored versus empirical concomitant therapy as first-line Helicobacter pylori treatment: a randomized clinical trial","volume":"12","author":"Lee","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"10","key":"10.1016\/j.clinre.2026.102928_bib0021","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1111\/jgh.15575","article-title":"Susceptibility-guided versus empirical treatment for Helicobacter pylori infection: a systematic review and meta-analysis","volume":"36","author":"Gingold-Belfer","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102928_bib0022","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jfma.2021.10.011","article-title":"Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial","volume":"121","author":"Hsieh","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.clinre.2026.102928_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13076","article-title":"14-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: a multicenter, open-label randomized noninferiority controlled trial","volume":"29","author":"Amiot","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.clinre.2026.102928_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820968736","article-title":"Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review","volume":"13","author":"Gisbert","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102928_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70013","article-title":"Managing Helicobacter pylori as an infectious disease: implementation of antimicrobial stewardship","volume":"30","author":"Hsu","year":"2025","journal-title":"Helicobacter"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:35:07Z","timestamp":1794342907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2210740126001749"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102928","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic\u2013therapeutic readiness in Helicobacter pylori management: Aligning diagnostic capability with therapeutic opportunity","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102928"}}